Variant clinical courses in children with immune thrombocytopenic purpura: Sixteen year experience of a single medical center;Çocukluk çaǧında immun trombositopenik purpura ve farklı klinik seyir: Tek merkezin 16 yıllık deneyimi

Turkish Journal of Hematology

Volumn 27, Issue 3, 2010, Pages 147-155

  Yaprak, Işin ^a   Atabay, Berna ^a   Durak, Ikbal ^a   Türker, Meral ^a   Öniz, Haldun ^a   Özer, Esra Arun ^a  

^a Izmir Tepecik Training and Research Hospital Eye Clinic   (Turkey)

Author keywords

Children; Chronic; Clinical course; Immune thrombocytopenic purpura; Outcome; Recurrent

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE;

ACUTE DISEASE; ADOLESCENT; ARTICLE; CHILD; CHRONIC DISEASE; DISEASE COURSE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RECURRENT DISEASE; REMISSION; SCHOOL CHILD; SEX DIFFERENCE; THROMBOCYTE COUNT; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 78449251862     PISSN: 13007777     EISSN: 13085263     Source Type: Journal    
DOI: 10.5152/tjh.2010.21     Document Type: Article

References (27)

1. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002;346:995-1008.
2. Nugent DJ. Childhood immunothrombocytopenic purpura. Blood Rev 2002;16:27-29.
3. Kühne T. Immune thrombocytopenic purpura in childhood: controversies and solutions. Pediatr Blood Cancer 2006;47(5 Suppl):650-652.
4. Belletrutti M, Ali K, Barnard D, Blanchette V, Chan A, David M, Luke B, Price V, Ritchie B, Wu J; Canadian Pediatric Chronic ITP Working Group; Canadian Pediatric Thrombosis and Hemostasis Network. Chronic immune thrombocytopenic purpura in children: a survey of the Canadian experience. J Pediatr Hematol Oncol 2007;29:95-100.
5. Ozer EA, Yaprak I, Atabay B, Türker M, Akşit S, Sarioǧlu B. Oral cyclic megadose methylprednisolone therapy for chronic immune thrombocytopenic purpura in childhood. Eur J Hematol 2000;64:411-415.
6. Ruggiero A, Annunziata ML, Lazzareschi I, Ridola V, Attinà G, Riccardi R. Chronic immune thrombocytopenic purpura in children: case reports of spontaneous recovery without splenectomy. Pediatr Hematol Oncol 2006;23:471-475.
7. Jayabose S, Levendoglu-Tugal O, Ozkaynkak MF, Visintainer P, Sandoval C. Long-term outcome of chronic immune thrombocytopenic purpura in children. J Pediatr Hematol Oncol 2004;26:724-726.
8. Donato H, Picón A, Martinez M, Rapetti MC, Rosso A, Gomez S, Rossi N, Bacciedoni V, Schvartzman G, Riccheri C, Costa A, Di Santo J. Demographic data, natural history, and prognostic factors of immune thrombocytopenic purpura in children: a multicentered study from Argentina. Pediatr Blood Cancer 2009;52:491-496.
9. Imbach P, Lilleyman JS, Hann IM and Blanchetter, V. S. (eds) (1999) Immune thrombocytopenic purpura. Pediatric Hematology, ed 2 Churchill Livingstone, London: Churchill Livingstone, 1999: 437-453.
10. Jayabose S, Levendoglu-Tugal O, Ozkaynak MF, Sandoval C. Recurrent immune thrombocytopenic purpura in children. Pediatr Hematol Oncol 2006;23:677-682.
11. Walker JH, Walker W. Immune thrombocytopenic purpura in childhood. Arch Dis Child 1961;36:649-657.
12. Kuhne T, Buchanan GR, Zimmerman S. Michaels LA, Kohan R, Berchtold W, Imbach P. A prospective comparative study of 2540 infants and children with newly diagnosed immune thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group. J Pediatr 2003;143:605-608.
13. Watts RG. Immune thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of Alabama. Clin Pediatr 2004;43:691-702.
14. Imbach P, Kühne T, Müller D, Berchtold W, Zimmeman S, Elalfy M, Buchanan GR. Childhood ITP: 12 months follow-up data from the Prospective Registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer 2006;46:351-356.
15. Paling A, Stefan DC. Immune thrombocytopenic purpura in childhood: a 10-year audit. Hematology 2008;13:175-180.
16. Glanz C, France E, Xu S, Hayes T, Hambidge S. A population-based multisite, cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics 2008;121:e506-512.
17. Dameshek W, Ebbe S, Greenberg L, Baldini M. Recurrent acute idiopathic thrombocytopenic purpura. N Engl J Med 1963;269:649-653.
18. Khalifa AS, Tolba KA, el-Alfy MS, Gadallah M, Ibrahim FH. Idiopathic thrombocytopenic purpura in Egyptian children. Acta Haematol 1993;90:125-129.
19. Vranou M, Platokouki H, Pergantou H, Aronis S. Recurrent immune thrombocytopenic purpura in childhood. Pediatr Blood Cancer 2008;51:261-264.
20. Roganovic J, Letica-Crepulja M, Dordevic L. Recurrent immune thrombocytopenic purpura in children. Pediatr Hematol Oncol 2008;25:243-244.
21. Wilson DB. Acquired platelet disorders. In: Nathan DG, Orkin SH, Ginsburg D, Look AT, editors. Nathan and Oski's Hematology of Infancy and Childhood. 6th ed. Philadelphia: WB Saunders, 2003: 1597-1630.
22. Conradi A, Diaz de Heredia C, Tussel Puigbert J, Tobena Boada L, Ortega Aramburu JJ. Chronic and recurrent immune thrombocytopenic purpura. Ann Pediatr (Barc) 2003;59:6-12.
23. Donato H, Picón A, Rapetti MC, Rosso A, Schvartzman G, Drozdowski C, Di Santo JJ. Splenectomy and spontaneous remission in children with chronic immune thrombocytopenic purpura. Pediatr Blood Cancer 2006;47:737-739.
24. Mantadakis E, Buchanan GR. Elective splenectomy in children with immune thrombocytopenic purpura. J Pediatr Hematol Oncol 2000;22:148-53.
25. El-Alfy MS, El-Tawil MM, Shahein N. 5- to 16-year follow-up following splenectomy in chronic immune thrombocytopenic purpura in children. Acta Haematol 2003;110:20-24.
26. Wang T, Xu M, Ji L, Yang R. Splenectomy for chronic immune thrombocytopenic purpura in children: a single center study in China. Acta Haematol 2006;115:39-45.
27. Yetgin S, Olcay L, Ozsoylu S, Hiçsönmez G, Gurgey A, Tuncer AM. Retrospective analysis of 78 children with chronic ITP: follow-up from 1976-1996. Pediatr Hematol Oncol 1997;14:399-412.